first
develop
assay
use
ang
ii
substrat
form
ang
new
method
involv
seri
four
reaction
use
synthet
ang
ii
start
substrat
angiiconvert
activ
measur
product
rate
lphenylalanin
phe
follow
proteolyt
cleavag
peptid
bond
carboxyl
terminu
schemat
reaction
fig
first
reaction
ang
ii
allow
react
purifi
convert
enzym
tissu
lysat
ang
ii
ang
convers
releas
carboxyl
termin
fig
coupl
reaction
expos
primari
amin
group
phenylalanin
amino
acid
hydrolyz
phenylalanin
ammonialyas
pal
rhodotorula
glutini
ultim
turn
fluoresc
probe
fig
illustr
purpos
color
convers
visibl
nake
eye
follow
reaction
shown
fig
typic
reaction
set
oper
format
either
dynam
endpoint
read
fluoresc
excit
intens
autom
detail
method
sinc
new
assay
detect
cleavag
carboxyl
phenylalanin
polypeptid
worth
note
biolog
activ
peptid
also
share
prolinephenylalanin
pf
dipeptid
motif
signatur
fig
among
peptid
also
cleav
cleav
peptid
bond
preced
caus
inactiv
potent
stimul
cardiac
contractil
apelin
exist
number
activ
polypeptid
form
aa
aa
aa
carri
dipeptid
motif
carboxi
termini
expect
react
therefor
ask
whether
new
phenylalanin
assay
also
adapt
measur
carboxypeptidas
activ
degrad
see
enzym
cleav
ang
ii
use
studi
valid
phenylalanin
assay
two
substrat
previous
made
recombin
solubl
murin
aa
extracellular
catalyt
segment
test
activ
use
mcaapk
dnp
sought
determin
dynam
perform
assay
doserespons
studi
fig
eight
reaction
twofold
serial
dilut
monitor
minut
presenc
phenylalanin
assay
regent
fig
amount
substrat
reaction
ang
ii
gave
similar
result
compar
b
show
reaction
condit
allow
complet
dose
separ
seri
result
also
show
rel
fluoresc
intens
reach
plateau
within
min
highest
group
fig
therefor
use
min
optim
firststep
reaction
time
follow
twostep
phenylalanin
assay
detail
method
evalu
suitabl
phenylalanin
assay
quantit
analysi
perform
analysi
ang
ii
convert
activ
use
first
incub
excess
quantiti
reaction
variabl
amount
substrat
min
follow
phenylalanin
reaction
substratefluoresc
depend
curv
deriv
use
nonlinear
regress
fig
perform
phenylalanin
assay
calcul
kinet
paramet
measur
catalysi
rate
ang
ii
respect
km
valu
ang
ii
vmax
valu
ang
ii
nmolminug
protein
nmolminug
protein
fig
note
show
similar
catalyt
effici
toward
ang
ii
substrat
reason
one
intend
applic
assay
measur
convert
activ
biolog
fluid
tissu
may
possess
lower
level
enzymat
activ
test
analyt
perform
assay
measur
activ
variou
concentr
use
ang
ii
substrat
plot
standard
curv
system
produc
virtual
background
signal
low
ng
enzym
could
still
sensit
detect
fig
b
good
linear
rang
activ
obtain
ng
nonlogerithm
scale
ang
ii
ng
ng
logarithm
scale
ang
ii
supplementari
figur
next
evalu
intraassay
interassay
precis
reproduc
sampl
contain
differ
amount
measur
reaction
ang
ii
result
subsequ
calcul
standard
curv
obtain
supplementari
tabl
show
intraassay
coeffici
variat
cv
rang
interassay
cv
rang
low
cv
valu
indic
high
reliabl
assay
also
compar
activ
result
obtain
phenylalanin
assay
exist
mcaapk
dnp
method
serial
dilut
seri
ad
reaction
either
mcaapk
dnp
ang
ii
peptid
measur
activ
directli
compar
method
measur
activ
correl
input
concentr
enzym
also
highli
correl
fig
emphas
two
substrat
rather
distinct
sequenc
fig
mcaapk
dnp
sequenc
origin
design
caspas
surrog
crossrecogn
therefor
specif
inhibitor
use
conjunct
mcaapk
dnp
measur
activ
exclus
attribut
instead
phenylalanin
assay
measur
either
combin
total
convert
activ
ang
ii
use
presenc
absenc
inhibitor
respect
next
set
test
whether
new
assay
faith
measur
activ
level
cell
system
adapt
cell
transfect
system
express
fc
tag
solubl
like
previou
exampl
shown
fig
express
transfect
cell
confirm
western
blot
fig
b
activ
could
detect
cell
lysat
cultur
medium
fig
activ
complet
abolish
presenc
inhibitor
reaction
also
expect
control
cell
transfect
empti
plasmid
produc
activ
sought
use
new
assay
comparison
mcaapk
dnp
measur
activ
serum
sampl
follow
singl
ip
inject
increas
activ
could
detect
earli
minut
fig
b
level
peak
hour
gradual
dissip
period
overal
two
method
show
virtual
ident
serum
profil
activ
n
indic
new
ang
ii
phenylalanin
method
sensit
measur
activ
complex
serum
sampl
inhibitor
use
neg
control
full
length
transmembran
protein
minim
present
serum
proteasemedi
separ
perform
mcaapk
dnp
phenylalanin
test
mous
serum
recombin
use
benchmark
control
order
crossrefer
two
assay
previous
report
us
minim
serum
activ
measur
mcaapk
dnp
fig
contrast
use
larg
volum
mous
serum
detect
convert
peptidas
activ
compar
ng
measur
phenylalanin
assay
use
ang
ii
peptid
fig
e
respect
result
suggest
ang
format
ang
ii
serum
larg
extent
although
convert
activ
rel
low
might
undetect
report
other
use
method
use
small
amount
carboxypeptidas
react
ang
ii
contribut
therefor
total
phenylalanin
intens
particularli
tissu
level
see
next
sought
measur
ang
iiconvert
activ
complex
tissu
lysat
first
conduct
control
experi
determin
background
level
assay
two
contribut
sourc
natur
exist
phenylalanin
tissu
phenylalanin
result
nonang
ii
substrat
abund
tissu
protein
use
mous
kidney
lysat
even
without
ang
ii
substrat
background
level
phenylalanin
read
like
endogen
phenylalanin
reaction
proceed
ang
ii
read
phenylalanin
level
increas
steadili
time
supplementari
fig
stark
contrast
reaction
maintain
constant
intens
phenylalanin
signal
ang
ii
absent
suggest
reaction
signal
deriv
ang
iiconvers
instead
protein
substrat
tissu
lysat
endogen
phenylalanin
level
tend
vari
mgdl
blood
depend
diet
next
perform
desalt
lysat
remov
endogen
phenylalanin
detail
method
subject
result
tissu
lysat
phenylalanin
assay
ang
ii
ad
reaction
expect
desalt
reduc
background
intens
major
mous
tissu
test
notabl
serum
supplementari
fig
therefor
adapt
desalt
step
tissu
prepar
subsequ
experi
assay
equal
perform
without
step
requir
subtract
baselin
phenylalanin
activ
addit
measur
kinet
ang
format
reaction
ang
ii
mix
kidney
lysat
follow
initi
accumul
ang
peak
min
total
level
gradual
subsid
like
reflect
degrad
newli
form
ang
contrast
phenylalanin
stabli
produc
throughout
cours
min
reaction
fig
evid
net
ang
level
influenc
rate
format
degrad
commonli
use
eia
method
may
truli
repres
ang
format
activ
contrast
activ
better
captur
phenylalanin
assay
attribut
stabil
phenylalanin
amino
acid
conduct
assay
mous
organ
comparison
mcaapk
dnp
assay
perform
without
inhibit
activ
level
estim
differ
two
measur
consist
publish
activ
promin
present
ileum
follow
kidney
fig
tissu
lysat
subject
phenylalanin
reaction
use
either
ang
ii
substrat
fig
respect
ileum
kidney
remain
highest
activ
addit
organ
includ
lung
stomach
also
display
high
carboxypeptidas
activ
interest
note
inhibit
reduc
phenylalanin
activ
variabl
extent
notic
ileum
kidney
heart
shown
play
essenti
role
ang
ii
devis
fluorometr
assay
measur
carboxypeptidasemedi
degrad
ang
ii
form
ang
method
sensit
detect
activ
cell
organ
lysat
base
detect
hydrolysi
carboxyl
termin
phenylalanin
octapeptid
ang
ii
similarli
cleavag
carboxyl
termin
phenylalanin
also
easili
accur
detect
assay
use
carboxi
mono
peptidas
control
paradigm
optim
reaction
condit
achiev
linear
perform
wide
dynam
rang
raa
ang
ii
convert
sever
peptidas
includ
produc
ang
act
receptor
counterbal
effect
trigger
ang
catalyt
properti
evok
interest
enzym
especi
possibl
therapeut
target
cardiovascular
renal
diseas
also
known
enzym
catalyz
domin
peptid
apelin
current
activ
commonli
measur
use
fluorometr
substrat
mcayvadapk
dnp
mcaapk
dnp
use
mcaapk
dnp
assay
benchmark
demonstr
phenylalanin
assay
produc
remark
consist
result
measur
activ
fig
phenylalanin
assay
comprehens
measur
ang
form
activ
may
complement
activ
assay
evalu
ang
ii
metabol
elisabas
method
measur
input
ang
ii
product
ang
howev
antibodybas
assay
intrins
finicki
input
substrat
peptid
tissu
lysat
amount
care
optim
achiev
linear
even
best
set
dynam
rang
less
one
order
magnitud
oppos
three
order
magnitud
rang
achiev
ang
ii
phenylalanin
assay
fig
clinic
import
raa
multitud
diseas
underscor
need
techniqu
measur
enzymat
activ
biolog
sampl
blood
tissu
new
method
could
broad
applic
analyz
biolog
clinic
sampl
instanc
use
pure
enzym
includ
known
ang
ii
convert
activ
prolylcarboxypeptidas
prcp
prolylendopeptidas
pepprep
alongsid
may
provid
meaning
comparison
kinet
paramet
well
tissu
specif
distribut
activ
carboxypeptidas
furthermor
sinc
demonstr
assay
also
suit
analyz
serum
tissu
lysat
potenti
applic
techniqu
clinic
sampl
possibl
sampl
volum
requir
test
diminut
make
feasibl
research
clinic
use
particular
import
new
test
may
shed
light
regul
ang
ii
degrad
health
diseas
state
anticip
organ
lysat
contain
complex
peptidas
activ
includ
contribut
continu
degrad
newli
form
angiotensin
peptid
previou
studi
measur
ang
format
appli
proteas
inhibitor
pmsf
bestatin
suppress
undesir
proteas
howev
broadspecif
inhibitor
may
also
compromis
effort
find
physiolog
relev
convert
enzym
might
sensit
inhibit
contrast
phenylalanin
approach
measur
level
stabl
amino
acid
phenylalanin
therefor
use
absenc
gener
proteas
inhibitor
still
note
caveat
new
assay
phenylalanin
result
like
reflect
combin
enzym
activ
attribut
phenylalanin
format
includ
limit
ang
ii
ang
convers
instanc
concurr
proteolyt
cleavag
ang
ii
peptid
addit
enzym
might
happen
prior
releas
phenylalanin
therefor
new
method
use
conjunct
select
combin
specif
peptidas
inhibitor
may
pursu
futur
toward
better
delin
vivo
ang
ii
ang
convert
enzym
new
method
also
use
measur
activ
share
carboxyl
termin
prolinephenylalanin
motif
ang
bioactiv
peptid
includ
bradykinin
catalyz
peptidas
remov
carboxyl
phenylalanin
fig
matter
assay
also
work
although
experiment
test
yet
admittedli
new
phenylalanin
assay
also
limit
use
complex
lysat
endogen
enzym
would
otherwis
spatial
inaccess
extracellular
angiotensin
peptid
react
fals
posit
vitro
assay
nevertheless
base
initi
test
new
phenylalanin
assay
simpl
complex
activ
procedur
sensit
robust
appli
assay
rang
diseas
model
hypertens
diabet
nephropathi
potenti
yield
import
insight
diseas
mechan
ang
ii
peptid
purchas
anaspec
san
jose
ca
usa
phenylalanin
detect
kit
purchas
sigmaaldrich
st
loui
mo
usa
substrat
mcaapk
dnp
purchas
enzo
life
scienc
farmingdal
ny
usa
antibodi
abcam
cambridg
usa
inhibitor
gift
millennium
pharmaceut
cambridg
usa
recombin
extracellular
domain
mous
term
fuse
x
tag
gener
lab
produc
largescal
invitrogen
custom
servic
carlsbad
ca
usa
report
kinet
measur
activ
phenylalanin
assay
serial
dilut
reaction
buffer
mm
trishcl
ph
mm
nacl
start
mgml
dilut
enzym
mix
ang
ii
mm
mm
substrat
enzym
mix
develop
phenylalanin
detect
kit
reaction
proceed
minut
room
temperatur
fluoresc
intens
time
seri
measur
nm
excit
nm
emiss
wavelength
reaction
perform
triplic
measur
activ
endpoint
fluoresc
read
peptidas
reaction
proceed
presenc
ang
ii
reaction
stop
minut
heat
inactiv
minut
reaction
mixtur
directli
ad
phenylalanin
detect
buffer
contain
enzym
mix
develop
plate
anoth
minut
fluoresc
read
measur
note
remov
protein
content
ad
kit
compon
suggest
manufactur
instruct
necessari
result
supplementari
figur
show
protein
content
neither
increas
background
level
imped
reaction
reaction
buffer
cell
serum
sampl
contain
mm
trishcl
ph
mm
nacl
measur
endogen
activ
serum
tissu
sampl
ad
ang
ii
substrat
lysat
first
desalt
use
zebatm
spin
column
thermo
fisher
scientif
san
jo
ca
usa
step
remov
endogen
phenylalanin
therefor
reduc
background
read
consider
larg
number
peptidas
includ
metallopeptidas
may
need
dival
ion
activ
reaction
buffer
desalt
sera
tissu
lysat
contain
addit
mm
mm
reaction
tissu
lysat
allow
proceed
minut
follow
heat
inactiv
phenylalanin
assay
reaction
use
kidney
sampl
desalt
kidney
lysat
incub
ang
ii
reaction
differ
time
point
reaction
stop
heat
phenylalanin
measur
describ
measur
kinet
constant
km
vmax
enzym
incub
variou
concentr
ang
ii
substrat
min
follow
heat
inactiv
phenylalanin
detect
rate
increas
fluoresc
intens
initi
phase
min
calcul
convert
protein
accord
substratefluoresc
intens
standard
curv
valu
kinet
constant
km
vmax
obtain
fit
correspond
data
equat
use
graphpad
prism
softwar
evalu
intraassay
precis
five
replic
sampl
contain
low
concentr
medium
concentr
high
concentr
prepar
measur
use
ang
ii
substrat
procedur
describ
evalu
interassay
precis
low
medium
high
concentr
sampl
prepar
intraassay
measur
repeat
daili
day
mean
standard
deviat
sd
sampl
calcul
coeffici
variat
cv
calcul
sdmean
dna
fragment
encod
extracellular
domain
mous
aa
fuse
human
fc
domain
ligat
hind
iii
xho
site
vector
invitrogen
human
embryon
kidney
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fb
transfect
plasmid
use
invitrogen
hour
transfect
cultur
media
cell
lysat
collect
separ
express
enzymat
activ
measur
western
blot
use
antihuman
igg
antibodi
thermo
fisher
scientif
ang
ii
phenylalanin
assay
respect
reaction
presenc
inhibitor
neg
control
activ
measur
use
mcaapk
dnp
substrat
black
microtit
plate
previous
sampl
either
cell
lysat
cell
cultur
medium
mous
serum
mous
tissu
lysat
ad
well
contain
reaction
buffer
mm
acid
ph
mm
nacl
triton
maapk
dnp
total
reaction
volum
experi
perform
triplic
room
temperatur
minut
neg
control
reaction
proceed
presenc
nm
inhibitor
activ
measur
fluoresc
intens
nm
excit
nm
emiss
wavelength
use
micropl
fluoresc
reader
biotek
instrument
inc
winooski
vt
usa
measur
dynam
format
ang
vitro
reaction
kidney
lysat
reaction
contain
ang
ii
lysat
incub
reaction
stop
differ
time
point
dilut
time
icecold
methanol
dilut
sampl
eia
buffer
quantiti
ang
determin
use
eia
kit
peninsula
laboratori
llc
san
carlo
ca
usa
per
manufactur
instruct
studi
anim
approv
northwestern
univers
anim
care
use
committe
protocol
experi
perform
accord
relev
guidelin
regul
eightweekold
femal
mice
purchas
tacon
farm
germantown
ny
usa
blood
activ
studi
mice
receiv
intraperiton
inject
subject
tailbleed
collect
blood
sampl
timeseri
blood
left
clot
room
temperatur
minut
centrifug
g
minut
collect
serum
inject
experi
serum
use
reaction
measur
endogen
peptidas
activ
tend
lower
activ
larger
volum
use
reaction
tissu
sampl
prepar
first
remov
blood
system
perfus
cold
pb
tissu
mice
homogen
cold
lysi
buffer
mm
tri
ph
mm
nacl
clear
lysat
obtain
follow
centrifug
g
minut
desalt
use
zebatm
column
thermofish
remov
endogen
phenylalanin
total
protein
concentr
determin
use
biorad
protein
assay
regent
biorad
sampl
use
final
mcaapk
dnp
phenylalanin
assay
describ
cite
articl
liu
p
et
al
fluorometr
method
measur
carboxypeptidas
activ
angiotensin
ii
sci
rep
doi
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
